ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Potassium Phosphate, Tribasic → 6-(2'-Chloro-4'-((5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)methyl)biphenyl-4-yl)-3,5-dimethylpyrazine-2-carboxamide

HRID 1930166
印刷

反応式

HRID 1930166 の反応式
[C:1]([C:4]1[N:9]=[C:8]([C:10]2[CH:15]=[CH:14][C:13](B(O)O)=[C:12](Cl)[CH:11]=2)[C:7]([CH3:20])=[N:6][C:5]=1[CH3:21])(=[O:3])[NH2:2].P([O-])([O-])([O-])=O.[K+].[K+].[K+].Br[C:31]1[CH:43]=[CH:42][C:34]([CH2:35][C:36]2[NH:40][C:39](=[O:41])[O:38][N:37]=2)=[CH:33][C:32]=1[Cl:44]>COCCOC.CO.O.Cl[Pd]Cl.C1(P(C2C=CC=CC=2)[C-]2C=CC=C2)C=CC=CC=1.[C-]1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=C1.[Fe+2]>[Cl:44][C:32]1[CH:33]=[C:34]([CH2:35][C:36]2[NH:40][C:39](=[O:41])[O:38][N:37]=2)[CH:42]=[CH:43][C:31]=1[C:13]1[CH:14]=[CH:15][C:10]([C:8]2[N:9]=[C:4]([C:1]([NH2:2])=[O:3])[C:5]([CH3:21])=[N:6][C:7]=2[CH3:20])=[CH:11][CH:12]=1
参加物反応条件実験手順後処理出典と根拠反応ノート

参加物

8

反応物 3

HCID 62657Potassium Phosphate, TribasicHCID 672865054-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)-2-chlorophenylboronic acid2 回HCID 1361605583-(4-bromo-3-chlorobenzyl)-1,2,4-oxadiazol-5(4H)-one2 回

生成物 1

HCID 1361605536-(2'-Chloro-4'-((5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)methyl)biphenyl-4-yl)-3,5-dimethylpyrazine-2-carboxamide収率 29.8%

試薬・触媒・溶媒 4

HCID 44119782Bis(cyclopenta-1,4-dien-1-yl(diphenyl)phosphane);dichloropalladium;iron(2+)触媒
HCID 887Methanol溶媒
HCID 962Water溶媒
HCID 80711,2-Dimethoxyethane溶媒

反応条件

温度
80 °C

実験手順

To a degassed solution of 4-(6-carbamoyl-3,5-dimethylpyrazin-2-yl)phenylboronic acid (Intermediate 5-1; 562 mg, 2.07 mmol) in DME (60 mL), methanol (15 mL) and water (15 mL) was added tripotassium phosphate (660 mg, 3.11 mmol), 3-(4-bromo-3-chlorobenzyl)-1,2,4-oxadiazol-5(4H)-one (Intermediate 23-1; 600 mg, 2.07 mmol) followed by (1,1′-bis(diphenylphosphino)ferrocene)-dichloropalladium(II) (DCM adduct) (341 mg, 0.41 mmol). The resulting mixture was stirred at 80° C. under nitrogen for 90 minutes. The reaction mixture was allowed to cool to ambient temperature evaporated and partitioned between DCM (100 mL) and 0.5M HCl (100 mL), the suspension was filtered (difficult as most of the material was a sticky gum) and the resultant material retained. Organic phase separated off, dried by passing through a phase seperating cartridge. Removal of the solvent under reduced pressure gave crude product which was combined with previously filtered material for chromatography. The crude product was purified by preparative HPLC (Waters—Xbridge Prep C18 5 μm), using decreasingly polar mixtures of water (containing 0.1% formic acid) and {MeOH(3):MeCN(1)} as eluents. Fractions containing the desired compound were evaporated to dryness to afford 6-(2′-chloro-4′-((5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)methyl)biphenyl-4-yl)-3,5-dimethylpyrazine-2-carboxamide (269 mg, 29.8%) as a colourless solid.

後処理

  1. temperatureto cool to ambient temperature
  2. customevaporated
  3. custompartitioned between DCM (100 mL) and 0.5M HCl (100 mL)
  4. filtrationthe suspension was filtered (difficult as most of the material
  5. customOrganic phase separated off
  6. customdried
  7. customseperating cartridge
  8. customRemoval of the solvent under reduced pressure
  9. customgave crude product which
  10. customThe crude product was purified by preparative HPLC (Waters—Xbridge Prep C18 5 μm)
  11. additionFractions containing the desired compound
  12. customwere evaporated to dryness

出典と根拠

ORDレコード
ord-dba5fb78daaf4429817b0dc0c22a4fb3
出典データセット
uspto-grants-2012_05
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08188092B2

反応ノート

このページの内容参加物反応条件実験手順後処理出典と根拠反応ノート